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Abstract
Background: Infectious bronchitis virus (IBV), a major pathogen of commercial poultry flocks, circulates in the form
of several serotypes/genotypes. Only a few amino-acid changes in the S1 subunit of wild-type IBVS proteins may
result in mutants unaffected by current vaccines.
Methods: Partial S1 gene sequences of 3 IBV isolates of the Moroccan Italy 02 genotype from vaccinated and
unvaccinated broiler chicken flocks, located in southern and central regions of Morocco, were amplified by RT-PCR,
sequenced, and aligned for phylogenetic and amino-acid similarity analyses.
Results: The three isolates were found genetically highly distant from known avian IBV based on partial sequences
of their S1 genes: gammaCoV/chicken/Morocco/I01/2011(IBV/Morocco/01), gammaCoV/chicken/Morocco/I30/2010
(IBV/Morocco/30), and gammaCoV/chicken/Morocco/I38/2013 (IBV/Morocco/38), nucleotide sequence identities
reached 89.5 % to 90.9 % among the three isolates. The deduced protein sequence identities ranged from 29.7 %
(between IBV/Morocco/38 and Egypt SCU-14/2013-1) to 78.2 % (between IBV/Morocco/01 and Spain/05/866). Amino
acid sequence comparison and phylogenetic analysis indicated the emergence of a new Moroccan genotype,
clustering with regionally related isolates from Spain (Spain/05/866) and belonging to a new sub-genotype.
Conclusion: Our sequencing results demonstrate a co-circulation of wild-type infectious bronchitis viruses in broiler
chickens. These results justify permanent monitoring of circulating strains in order to rationally modify vaccination
strategies to make them appropriate to the evolving field situation.
Keywords: Infectious bronchitis virus, Phylogenetic analysis, New genotype, Morocco
Introduction
Infectious bronchitis (IB) is one of the most contagious
diseases that affect poultry worldwide and is responsible
for severe economic losses. Clinically, the disease causes
respiratory distress, drop in egg production and quality
in layers. Some strains of IBVare associated with neph-
ritis [1–3].
Infectious bronchitis virus (IBV) is a member of the
species Avian coronavirus, genus Gammacoronavirus
(Nidovirales: Coronaviridae: Coronavirinae) [4]. IBV has
a linear, single-stranded RNA genome of positive polar-
ity of approximately 27 kb in length and produces
enveloped virions. IBV particles consist of three major
structural proteins: spike (S) glycoprotein, membrane
(M) protein, and nucleocapsid (N) protein. The spike of
IBV is formed by post-translational cleavage of S into
two separate polypeptide components, S1 and S2 [5, 6].
S1 mediates virion attachment to IBV host cells and is a
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major target of neutralizing antibodies in chickens.
Genotype evolution of IBV is associated primarily with
changes in the S1amino-acidsequence [7, 8]. Hence, the
evolutionary characterization of IBV is mainly based on
the analysis of the variable S1 gene or the expressed S1
protein [9, 10].
Different IBV variants are distributed globally. Some of
these variant are endemic only in particular regions,
while others circulate worldwide [11]. More than 20 dif-
ferent IBV serotypes are differentiated worldwide that
evolved from genomic insertions, deletions, substitutions,
and/or RNA recombinations of the S1 gene [12–14]. This
large diversity of serotypes is a major reason why commer-
cial vaccines often fail or are only partially efficacious,
and, therefore, new IB outbreaks continue to occur [1].
The first isolation and characterization of IBV from
poultry flocks in Morocco was reported by El-Houadfi et al.
in 1986 [15]. Six isolates were obtained, of which isolates
designated D, E, F, H, and M were found to be sero-
logically related to the Massachusetts (Mass) serotype,
whereas the sixth isolate, G, differed from the Mass sero-
type and other serotypes known at the time. Importantly,
El-Houadfi et al. demonstrated that Mass-based IBV
vaccines provided poor protection against infection with
isolate G [15]. In 2004, Alarabi conducted a study to
determine the relationship between IBV and nephropa-
thogenic disease outbreaks observed in broiler flocks in
Morocco between 1996 and 2000. Three different groups
of IBV isolates were identified using RT-PCR coupled with
restriction fragment length polymorphism (RFLP). Group
I belonged to the Mass serotype, whereas groups II and III
were distinct. Isolate 12/97 of group III, found to be
closely related to isolate G, caused more severe kidney
lesions and higher lethality in experimentally infected
animals compared to isolate 7/97 of group II [16]. In
2005, El Bouqdaoui et al., while studying nephropatho-
genic IBV using RT-PCR and RFLP techniques, identified
five genotypes, three of which differed from vaccine
strains [17].
The Moroccan poultry industry has developed signifi-
cantly under the framework "Plan Green Morocco" and
meets the growing domestic consumer demand for poultry
products, including meat and eggs The industry generates
a turnover of around 30 billion dirhams/year, totaling
mean investments of around 8.7 billion dirhams/year. The
official data regarding the general poultry rearing systems
in Morocco are: broiler production, 450 million/year
(among 6,800 farms); layers: 20 million/year (250 farms);
turkeys: 12 million/year (25 % imported d-old chicks);
broiler breeders: 3.2 million/year (70 % imported from
Spain and 30 % from other European countries); 48 hatch-
eries. The Interprofessional Federation of Poultry Sector
(FISA) aims to develop exports of poultry products in par-
ticular to Northern and Western Africa. FISA is affiliated
with Association of Moroccan Exporters (ASMEX) under
the objective of promoting poultry product export in
Africa, including chicks, hatching eggs, and compound
feed for poultry. In 2012, 6.7 million hatching eggs and
1.9-million–d-old chicks were exported to Mauritania,
Mali, Cameroon, Côte d'Ivoire, and Senegal, and 25,000
tons of compound feed were exported to Mauritania.
Breeder chicks (182,000) were imported in January 2014
(an increase of 28 % compared to 2013). However, imports
of layer and broiler breeder and turkey poults declined in
recent years, mainly due the development of local
production.
Three IBV vaccines are used in Morocco to protect
the industry: 793B, Arkansas, and Mass. The Mass type
has been used as of 1970 (H120, Ma5, and modified
Mass strains), whereas 793B (4/91 and CR88 strains)
and Arkansas vaccines were introduced in 2000 and
2013, respectively. New IBV serotypes and genotypes can
emerge as a result of only very few changes in the amino
acid sequence of the S protein. Vaccination programs
largely rely on the use of the IBV Massachusetts strain,
which is also the most commonly used IBV vaccine
strain in Morocco. However, despite the use of this vac-
cine, the common presences of IB in vaccinated chickens
continue to have a major negative economic impact [18].
In this study, IB was diagnosed between January 2010
and December 2013 in southern and central regions of
Morocco. Suspected IBV infections were found in 47
commercial broiler chicken farms. Among these, three
flocks showed severe clinical signs and mortality. The
aim of the present study is to characterize a new emer-
ging genotype of IBV from these outbreaks using mo-
lecular techniques, and to determine the relationship to
reference IBV strains by nucleotide sequence analysis.
Results
Case history
Infectious bronchitis was diagnosed between January 2010
and December 2013 in southern and central regions of
Morocco. Suspicious IBV infections (prominent respira-
tory disease) were found in broiler chickens from 47 com-
mercial farms. The flocks had been vaccinated against
Newcastle disease and infectious bursal disease (Table 1).
Among these farms, three flocks had severe respiratory
signs and experienced increased mortality. The first flock,
located in southern Morocco (Marrakech), was 26 d old
and was the only flock that had been vaccinated with the
H120 live IB vaccine by spray on d 7 and 21. The second
flock, located in central Morocco (Khamisset), was 24 d
old, and the third flock, located also in central Morocco
(Rabat) was 20 d old. Clinical presentation started with
respiratory depression and distress, including nasal dis-
charge, sneezing, coughing, and rales. Other signs in-
cluded conjunctivitis and watery eyes. Within 10 d after
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the appearance of the disease, lethality increased from
10 % to 30 % of the total flocks. Post-mortem examination
of dead birds revealed increased tracheal mucus, slight
congestion, and presence of catarrhal exudates in the nasal
turbinate and trachea.
IBV isolation and identification
We obtained a total of 47 Moroccan field isolates of IBV
from the 47 affected farms and were able to distinguish
them based on sequences of the hypervariable region
(HVR) 3 of their S1 regions (nucleotides 700–1095). Of
those isolates, three isolates, classified as the Moroccan
Italy 02 genotype, underwent further sequencing to
include all three hypervariable S1regions (nucleotides 1–
1,095). These three IBV strains were isolated from tra-
chea, lungs, and kidneys of broiler chickens. Between
the first and fourth passage, virus propagation from the
three suspect samples in specific pathogen-free eggs
resulted in characteristic IBV lesions (e.g., curled and
dwarfed embryos with head pressed over the feet and
covered by a thickened amnion)in 90 %–100 % of the
embryos. Results of both RT-PCR targeting the IBV N
gene and RT-PCR using primers amplifying a partial se-
quence of the IBV S1 gene were positive, confirming the
identity of the three isolates. The amplified partial S1
fragments (approximately 700 bp in length) of the three
isolates were sequenced. The sequences were submitted to
GenBank and assigned the accession numbers KJ701019,




01), respectively (Table 1).
Sequence analysis
Partial S1 gene sequences of the three IBV isolates were
sequenced. The nucleotide sequence and deduced amino
acid sequences (Table 2) of these IBV isolates were
blasted and compared with the reference and variant
strain sequences retrieved from GenBank from different
regions of the world. IBV isolates (IBV/Morocco/30,
IBV/Morocco/38, and IBV/Morocco/01) were found to
have different and unique partial S1 sequences compared
to reference strains. The sequences of the three isolates
have a nucleotide sequence identity between 91.6 %
(IBV/Morocco/38 and IBV/Morocco/01) and 94.8 %
(IBV/Morocco/30 and IBV/Morocco/01) when com-
pared to each other and from 29.7 % (IBV/Morocco/38
or IBV/Morocco/30 and Egypt SCU-14/2013-1)to 78.2 %
(IBV/Morocco/01 and Spain/05/866) when compared to
non-Moroccan IBV strains.
The deduced amino-acid sequence identities of
Moroccan IBV isolates ranged from89.4 % (between
IBV/Morocco38 and IBV/Morocco/01) to 90.9 % (between
IBV/Morocco/38, IBV/Morocco/30and IBV/Morocco/01)
when compared to each otherand from 12.9 % (between
IBV/Morocco/38 and Egypt SCU-14/2013-1)to 76.8 % (be-
tween IBV/Morocco/30 and Spain/04/22-1 of the Spanish
Italy 02 genotype), [19] when compared to non-Moroccan
IBV strains (Table 2). The alignment of the Moroccan IBV
isolates amino-acid sequences with that of reference strain
H120 identified the most variable regions in residues 62–
77 and 117–131 (numbering in reference to the H120
strain, Fig. 1). Insertions in the partial S1 subunit of the
three Moroccan strains were found at positions119, 120,
143, and 144 (Fig. 1).
The partial S1 protein sequences of the Moroccan iso-
lates were 69.4 % to 76.8 % homologous to those from
genotype Italy-02 (Italy 02 [AJ457137]; Italy 497/02-1
[DQ901377]; Spain/05/866 [DQ386102]; Spain/04/22-1
[DQ386100]; Spain/04/221[DQ386103]) but were <66.5 %
homologous to the remaining reference strains (Table 2).
Phylogenetic trees were constructed from the nucleo-
tide and deduced amino-acid sequences of the partial S1
glycoprotein genes of Moroccan IBV isolates and non-
Moroccan IBV referenced strains. The three Moroccan
IBV isolates and Spanish isolates of the Italy 02 genotype
formed a common branch (Fig. 2), but they clearly clus-
tered into 2 distinct sub-genotypes within the group.
The sequence analysis of the partial S1 gene demon-
strated that Moroccan isolates represent a unique sub-
genotype compared to other reference strains of various
countries and are distantly related to African, European,
and American strains.
Discussion
IBV was detected in poultry in Morocco in the 1980s, and
in more recent years, outbreaks of IB were reported re-
peatedly [15–17]. The present study suggests that a new
genotype, represented by the three new IBV isolates de-
scribed here, has been circulating in Morocco since at least
2010 (IBV/Morocco/30, accession number: KJ701020).
Table 1 Characterization of Moroccan infectious bronchitis virus
isolates from broiler chickens
Isolate
designation




Date of isolation GenBank
accession no.
Moroccan 30 26 7 and 21 (IBV)a May 2010 KJ701020
14 (NDV)b
18 (IBDV)c
Moroccan 38 24 7 (NDV)b December 2013 KJ701019
22 (IBDV)c
Moroccan 01 20 5 (NDV)b April 2011 KM594187
18 (IBDV)c
aIBV = Infectious bronchitis virus, bNDV = Newcastle disease virus,
cIBDV = Infectious bursal disease virus
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Phylogenetic analyses comparing the partial S1 gene
sequences of the three Moroccan field isolates with
those of reference and variant strain sequences revealed
that the Moroccan isolates were 69.4 % to 76.8 % hom-
ologous with Spanish isolates of the Italian 02 genotype
[19]. This similarity can be explained by the geographical
proximity and close transboundary of Morocco and
Spain. Moreover, these two countries have an ancient
history of commercial exchanges. In addition, Spain is
the most frequent country that exports breeder chicks to
Morocco (exports areunder the control of Office
National de Sécurité Sanitaire des ProduitsAlimentaires,
http://www.onssa.gov.ma/).
The deduced amino-acid sequences of Moroccan IBV
isolate proteins demonstrated that the Moroccan isolates
represent a unique genotype compared too ther refer-
ence strains of various countries. These Moroccan iso-
lates are only distantly related to African, European, and
American strains. The origin of this novel genotype
remains to be identified. In addition to population diver-
sity [20–22], widespread use of various vaccines made
from heterotypicIBVs in the field, recombination as a
consequence of mixed infections, or a decrease of
dominant serotypes as a result of vaccination may play
important roles in the emergence of such novel genetic
variants in Morocco.
Alignment of the partial S1 glycoprotein sequence of
Moroccan IBV isolates with thatof published non-
Moroccan IBV strain, H120, identified most sequence
variations between residues 62–77 and 117–131 (Fig. 1).
Both of these sequence regions correspond to known
HVR, mainly HVR1residues 50–69, and HVR2, residues
117–131, of the IBVS1 gene. HVR1 and HVR2 contain
sequences that have been associated with specific IBV se-
rotypes [7, 23] andserotype-specific neutralizing epitopes
[8]. The nucleotide S1sequences of IBV serotypes com-
monly differ by 20 to 25 % [24], but amino acid S1 se-
quences of some serotypes differ by as little as 2 % [25].
The HVRs are associated with two separate viral neutra-
lizing and conformationally-dependent epitopes [7, 26].
The insertions of four amino acids in the S1 subunit of
the three Moroccan strains possibly havesome signifi-
cance relatedto S1 functions (e.g., neutralization pheno-
types, virus tropism) [7, 25, 27–29]. Further studies are
needed to determine the role of theseinsertions in the S
glycoprotein [30], which might be related to reported
changes in the clinical manifestations of IB.
In the phylogenetic tree shown in Fig. 2, the Moroccan
IBV isolates formed a distinct cluster withthe Spanish
isolates of the Italy 02 genotype (supported by a high
bootstrap value: 96). The Spanish IV genotype was pre-
viously established as a new genotype based on the
Table 2 Nucleotide and amino acid identities of IBV Moroccan isolates and reference strains
S1 gene nucleotide identity (%)
Strains 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
1. IBV/Morocco/38 100 93.5 91.6 74.3 74 73.8 73.2 72.6 65.6 61.8 62 56.1 61.5 53 46.3 62 31.5 29.7 31.5
2. IBV/Morocco/30 90.9 100 94.8 77.7 77.7 77.4 76.7 76.2 68.7 65.2 65.4 58.5 65.1 49.5 48.2 65.4 31.46 29.7 33
3. IBV/Morocco/01 89.4 90.9 100 78.2 77.8 77.8 76.8 76.3 69.9 65 65 59.1 65.7 48.8 49.3 65 33.7 31.8 33.7
4. Spain/05/866 73.6 75.8 75.6 100 98.3 98.3 93.7 92.9 77.5 71.3 71.6 63.9 71.6 41.6 52.9 71.6 75.2 35.5 37
5. Spain/04/22-1 73.2 76.8 74.6 96.5 100 97.7 93.9 93.5 78.1 70.8 71 63.7 71.4 41.8 52.7 71 75.2 35.5 37
6. Spain/05/221 72.7 76.3 75.1 95.4 94.8 100 93.1 93.1 78.2 71.4 71.6 64.3 71.6 42.1 53.1 71.5 75 35.7 37
7. Italy-02 71.3 74.8 73.6 89.7 91.4 89.7 100 97.1 74.6 71 71.2 65.1 69.8 4.3 52.3 71.2 73.3 35.3 36.4
8. It/497/02-1 69.4 73.3 71.6 90.2 92 91.4 93.1 100 75.6 70.4 70.6 64.2 70.4 41.8 52.1 70.6 74.1 34.9 35.7
9. 4/91 63.6 65.3 66.5 76.1 76.1 76.7 72.2 72.2 100 74.14 74.3 60.6 73.4 38.4 48.9 74.3 71.5 34.9 35.9
10. H120 58.8 61.8 61.4 68.4 67.2 66.1 66.1 64.9 65.3 100 99.4 61.1 72.2 35.9 45.9 99.4 69.2 33.1 35
11. Ma5 59.3 62.3 61.9 68.9 67.8 66.7 66.7 65.5 65.3 99.4 100 61.3 72.4 36.1 46.1 100 69.3 33.1 35
12. D274 55.1 57.3 58.4 66.5 65.9 67 67.6 65.9 61.9 58.9 58.9 100 58.8 33.8 42.4 61.3 61.1 27.9 29.5
13. Qx 60 62 62.6 68.9 67.8 66.7 67.8 66.1 69.3 72 72.6 60.2 100 37.3 47.9 72.4 70.2 32.1 32.8
14. TN556/07 52.7 48.5 48.1 42.1 42.5 42.9 40.8 42.1 41 34.4 34.9 36.1 37.4 100 58.7 36.1 38.7 22 22.2
15. TN296/07 37.3 38.6 39.5 45.9 44.8 44.8 44.5 44.3 43.7 38.5 39 38.2 40.7 41.6 100 46.1 49.2 28.2 28.5
16. NGA/A116E/2006-1 59.3 57,9 60,41 68.9 67.8 66.7 66.7 65.5 65.3 99.4 99.4 58.9 72.6 34.9 39 100 69.3 33.1 35
17. Ark/C6d 61.3 63.8 61.9 73.7 73.7 73.2 72.1 72.1 67.1 63.9 64.4 62.5 68.9 39.4 42.4 64.4 100 34.5 36.4
18. Egypt/SCU-14/2013-1 12.9 14.5 13.6 16.9 17.5 16.9 16.4 16.4 14.3 16.5 17 12.6 17.1 10.4 11.6 17 16.1 100 81.8
19. Egypt/Beni-Suef/01 13.8 14 14.6 18 18.6 18 17.5 17.5 15.4 17 17.6 14 18.8 10.7 11.4 17.6 17.2 81.3 100
S1 protein amino acid identity (%)
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Fig. 1 Alignment of partial amino acid S1 sequences of the obtained Moroccan IBV isolates with the H120 referencestrain (amino acids 1–216)
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mosaic nature of its S1 gene. Viral neutralization studies
revealed Italy 02 and Spanish IV genotypes are subtypes
within a common serotype [19].
Conclusion
This molecular study has revealed that a new genotype
can emerge as a result of only a few changes in the
amino acid composition in the S1subunit of the virus
Sprotein [25]. This is the first report of identification
and genotyping of emergent IBV isolates in Morocco,
which indicate the circulation of previously unknown
IBV variants in both vaccinated and unvaccinated broiler
chickens.
Our data provide evidence of a new emerging geno-
type in Morocco. Three IBV field isolates were different
from published referenced strains in nucleotide and
amino acid sequences and clustered into a separate
branch based onphylogenetic analysis. All Moroccan
IBV variants presented specific nucleotide and amino
acid sequence insertions in the S1 gene in comparison
to the Massachusetts vaccine strain that might be associ-
ated with the occurrence of clinical disease in vaccinated
flocks. Further investigation related to cross protection
and pathogenicity of this new genotype detected in this
country are needed.
Methods
Tissue sampling from chickens with suspected IBV
infection
Tissue samples from trachea, lungs, and kidneys were
obtained from 10 birds from each flock, placed on ice,
and transferred to the laboratory in sterile transport
medium containing 5 % antibiotics (20,000 U/ml of
penicillin, 10,000 μg/ml of streptomycin, and 5,000 μg/ml
of kanamycin). These samples were used for virus
isolation.
Virus isolation
Virus isolation was performed by inoculation of 9–11-d-
old, embryonated, specific pathogen-free hen’s eggs with
200 μl of 10 % tissue homogenates. Eggs were incubated
at 37 °C and candled daily. Embryos that died within
24 h after inoculation were discarded. On d 2 after in-
oculation, three eggs were chilled at 4 °C for 2 h, and
the allantoic fluids were harvested, centrifuged at
8,000 rpm (xxx x g) for 15 min, and stored at −80 °C.
The remaining eggs were further incubated for 5 more d
and observed for typical embryonic lesions of IBV infec-
tion, such as dwarfing, stunting, and curling. Stored
allantoic fluids were further passaged three times in








































Fig. 2 Phylogenetic relationships of the obtained Moroccan isolates and selected reference strains based on partial S1 nucleotide sequences
determined using MEGA 5.0 with the Clustal W method. Numbers along the branches refer to bootstrap values
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harvested and tested for the presence of IBV using rRT-
PCR.
RNA extraction
Viral RNA was extracted from infected allantoic fluids
using the MagMax Express semi-automatic magnetic
particle extractor (Life Technologies, Grand Island, NY)
according to the manufacturer’s instructions. Allantoic
fluid samples and reagents were dispensed into X-well
microplates prior to magnetic particle processing. After
processing, each sample of extracted RNA recovered
from the wells of the plates was subjected toRT-PCR
amplification.
Real time RT-PCR for nucleocapsid gene detection
The oligonucleotides and the probe used for initial
screening of IBV were described previously [31]. These
oligonucleotides and the probe target the relatively con-
served IBV N gene at nucleotide positions 741–1077 of
the IBV Massachusetts H120 reference strain (GenBank
accession number: AM260960). RNase free water and
Newcastle disease virus strain (HB1) were included as
negative controls. One-step RT-PCR was performed with
12.5 μl of 2× RT-PCR buffer mix, 0.5 μlof MgSO4
(50 mmol/l), 0.5 μl of Rox reference dye (25 mmol/l, Life
Technologies), 0.5 μl of Moloneymurine leukemia virus
reverse transcriptase (200 U/μl), 0.5 μlof Taq DNA poly-
merase (Life Technologies), 0.5 μl of primers (0.2 μmol/
l), 0.25 μl of probe (0.1 μmol/l), and 5 μl of RNA tem-
plate to make a final volume of 25 μl.The reaction was
carried out using a StepOne Plus real-time PCR system
(Smart Cycler, Cepheid, Sunnyvale, CA) at 50 °C for
15 min, 95 °C for 5 min, and followed by 40 cycles of 9 °C
for 15 s; 60 °C for 45 s; 72 °C for 30 s, and a final extension
step of 74 °C for 5 min. Amplifications were recorded and
analyzed, and the threshold cycle (Ct) was determined
with StepOne software (Smart Cycler).
RT-PCR for S1 gene detection and DNA sequencing
Amplification of partialS1 gene sequences by RT-PCR was
performed using the forward S1S15’ mod (5’-TGA-AAA-
CTG-AAC-AAA-AGA-3’) and reverse S1CK2 (5’-CNG-
TRT-TRT-AYT-GRC-A-3’) primers [32]. RT-PCR was
performed using the Applied Biosystems kit protocol (Life
Technologies). The RT reaction was performed in a 20 μl
reaction mixture containing 2 μl of buffer (10×), 2.5 μl of
MgCl2 (25 mmol/l), 2.5 μl of dNTP (10 mmol/l), 0.75 μl
of each primer (10 μmol/l), 10.2 μl of sterilized water, 0.5 μl
of RNAase inhibitor (20 U/μl), 0.3 μl of RT (50 U/μl), and
0.5 μl of Gold Taq polymerase (5 U/μl). The PCR products
were analyzed on a 1 % agarose gel.
Partial RT-PCR products of the S1 gene (700 bp) con-
taining HVR1, HVR2, and HVR3 were purified using the
Gene Clean Kit (ExoSAP-IT, Affymetrix, Santa Clara,
CA) according to the manufacturer’s instructions. Purified
PCR products were used as templates for sequencing
using the BigDye® Terminator v1.1 Cycle Sequencing Kit
(Life Technologies). The second purification step was per-
formed using the Big Dye XTerminator Purification Kit
(Life Technologies). Purified PCR products were se-
quenced from both directions using the same primers
(S15’ mod and CK2).
Nucleotide sequence and deduced amino-acid-sequence
analyses
Assembly and analysis of sequence data were conducted
using the BioEdit Software version 5.0.9 [33]. The open-
source BLAST program (National Center for Biotechnology
Information, Bethesda MD, http://blast.ncbi.nlm.nih.gov/
Blast.cgi) was used for sequence comparison. Nucleotide
sequence and deduced amino acid sequences were aligned
using ClustalW and MEGA software Version 6.0 [34].
Phylogenetic analyses and tree construction for partial S1
glycoprotein gene sequences were generated using the
neighbor-joining method with 1,000 bootstrap replicates
with MEGA.
Genbank accession numbers of reference IBV variants
Ark/C6d (EU283056); D274 (X15832); Egypt/Beni-Suef/01
(JX174183); Egypt/SCU-14/2013-1 (KF731612); H120
(M21970); Italy-02 (AJ457137); Italy It/497/02-1 (DQ90
1377); Ma5 (AY561713); QX (AF193423); Spain/04/22-1
(DQ386100); Tunisia TN296/07 (FJ716133); Tunisia
TN556/07 (FJ716132); Spain/05/866 (DQ386102); Spain/
04/221 (DQ386103); Isolate Q1 (AF286302); SARS
(D14056); Strain 04/91 (AF093794);NGA/A116E7/2006
(FN430415).
Abbreviations
IBV: Infectious bronchitis virus; IBV/Morocco/01: gammaCoV/chicken/
Morocco/I01/2011; IBV/Morocco/30: gammaCoV/chicken/Morocco/I30/2010;
IBV/Morocco/38: gammaCoV/chicken/Morocco/I38/2013; IB: Infectious
bronchitis; S: Spike; M: Membrane; N: Nucleocapsid; HVR: Hypervariable
regions.
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